ATE324439T1 - Zelllinien zur heterologen expression von genprodukten mit humanem glykosilierungsmuster - Google Patents

Zelllinien zur heterologen expression von genprodukten mit humanem glykosilierungsmuster

Info

Publication number
ATE324439T1
ATE324439T1 AT03776861T AT03776861T ATE324439T1 AT E324439 T1 ATE324439 T1 AT E324439T1 AT 03776861 T AT03776861 T AT 03776861T AT 03776861 T AT03776861 T AT 03776861T AT E324439 T1 ATE324439 T1 AT E324439T1
Authority
AT
Austria
Prior art keywords
cell
gene product
starting
dna sequence
high yield
Prior art date
Application number
AT03776861T
Other languages
English (en)
Inventor
Volker Sandig
Karsten Winkler
Uwe Marx
Tobias Wermelinger
Original Assignee
Probiogen Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiogen Ag filed Critical Probiogen Ag
Application granted granted Critical
Publication of ATE324439T1 publication Critical patent/ATE324439T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT03776861T 2002-10-04 2003-10-06 Zelllinien zur heterologen expression von genprodukten mit humanem glykosilierungsmuster ATE324439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02022194A EP1405908A1 (de) 2002-10-04 2002-10-04 Herstellung von Zelllinien zur heterologen Expression

Publications (1)

Publication Number Publication Date
ATE324439T1 true ATE324439T1 (de) 2006-05-15

Family

ID=31985049

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03776861T ATE324439T1 (de) 2002-10-04 2003-10-06 Zelllinien zur heterologen expression von genprodukten mit humanem glykosilierungsmuster

Country Status (9)

Country Link
US (1) US20060148085A1 (de)
EP (2) EP1405908A1 (de)
JP (1) JP2006500937A (de)
AT (1) ATE324439T1 (de)
AU (1) AU2003286135B2 (de)
CA (1) CA2501218A1 (de)
DE (1) DE60304881T2 (de)
DK (1) DK1546328T3 (de)
WO (1) WO2004031383A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150005720A (ko) 2004-02-18 2015-01-14 크로모셀 코포레이션 신호 프로브를 이용하는 방법 및 물질
ATE443128T1 (de) * 2004-10-22 2009-10-15 Novozymes As Stabile genomische integration mehrerer polynukleotidkopien
WO2009114693A1 (en) * 2008-03-12 2009-09-17 Wyeth Method for identifying cells suitable for large-scale production of recombinant proteins
EP2105505A1 (de) 2008-03-28 2009-09-30 Celonic AG Verfahren und Materialien zur wiederholbaren Erzeugung hochproduktiver Zelllinien für rekombinante Proteine
US20110136236A1 (en) * 2008-04-21 2011-06-09 Unitargeting Research As Genetically modified eukaryotic cells
EP2527448A1 (de) 2011-05-23 2012-11-28 Novozymes A/S Gleichzeitige standortspezifische Integrationen von mehreren Genkopien in faserige Pilze
FR2981946B1 (fr) 2011-10-28 2015-02-20 Lfb Biotechnologies Unites de transcription et leur utilisation dans des vecteurs d'expression (yb2/0)
CN109804072A (zh) 2016-10-25 2019-05-24 诺维信公司 地衣芽孢杆菌中flp介导的基因组整合
GB201703417D0 (en) 2017-03-03 2017-04-19 Ge Healthcare Bio Sciences Ab Method for cell line development
EP4399317A4 (de) * 2021-09-09 2025-05-14 BioConsortia, Inc. Blinde editierung von polynukleotidsequenzen
WO2024137877A1 (en) * 2022-12-21 2024-06-27 Clara Foods Co. Systems and methods for high yielding recombinant microorganisms and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130364A (en) * 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6086913A (en) * 1995-11-01 2000-07-11 University Of British Columbia Liposomal delivery of AAV vectors
US6534314B1 (en) * 1996-06-14 2003-03-18 Massachusetts Institute Of Technology Methods and compositions for transforming cells
WO1999025840A1 (en) * 1997-11-18 1999-05-27 Pioneer Hi-Bred International, Inc. A novel method for the integration of foreign dna into eukaryoticgenomes
CN1455817A (zh) * 2000-07-21 2003-11-12 (由农业部部长代表的)美利坚合众国 用于在真核基因组中置换、转移和富积dna的方法

Also Published As

Publication number Publication date
JP2006500937A (ja) 2006-01-12
EP1405908A1 (de) 2004-04-07
AU2003286135A1 (en) 2004-04-23
DE60304881T2 (de) 2007-04-19
EP1546328A1 (de) 2005-06-29
DE60304881D1 (de) 2006-06-01
EP1546328B1 (de) 2006-04-26
AU2003286135B2 (en) 2009-01-15
WO2004031383A1 (en) 2004-04-15
DK1546328T3 (da) 2006-08-07
US20060148085A1 (en) 2006-07-06
CA2501218A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
DE60304881D1 (de) Zelllinien zur heterologen expression von genprodukten mit humanem glykosilierungsmuster
EP2336330A3 (de) An der Entwicklung von Pflanzenfasern beteiligte Polynukleotide und Polypeptide sowie Verfahren zur Verwendung davon
DK0917571T3 (da) Hidtil ukendt agoutirelateret gen
DE50301836D1 (de) Verfahren zur fermentativen Herstellung von Aminosäuren und Aminosäure-Derivaten der Phosphoglycerat-Familie
DE69928263D1 (de) Verfahren zur herstellung in vitro von rekombinierten nucleotidsequenzen, und so hergestelte genbanken und sequenzen
EP2258722A3 (de) Antikörper gegen Fibroblasten Wachstumsfaktor-ähnliche Polypeptide
EP1624065A3 (de) Agarase und Gen dafür
DE502004000547D1 (de) Verfahren zur fermentativen Herstellung von L-Methionin
AU2003238717A1 (en) POLYPEPTIDES HAVING Alpha- H-Alpha-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
ATE542913T1 (de) Promotorvarianten zur expression von genen in einer pilzzelle
DE60316152D1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
ATE387497T1 (de) Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen
ATE298747T1 (de) Verfahren zur herstellung von 5- hydroxybenzo(b)thiophen-3-carbonsäure
EP1038969A3 (de) Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien
WO2000077234A3 (es) Procedimiento de produccion de licopeno
WO2002098455A8 (en) Production of recombinant human arylsulfatase a
DE60302776D1 (de) Verfahren zur rekombinanten Herstellung von Polypeptiden
WO2002008443A1 (fr) Dispositif destine a marquer une proteine au moyen d'un systeme de synthese de proteine acellulaire d'embryon de ble
EP1365023A4 (de) Neue d-aminoacylase kodierende dna und verfahren zur herstellung von d-aminosäure unter verwendung derselben
AU2002210420A1 (en) Novel nucleotide sequences coding for the luxr gene
DE50002865D1 (de) Verfahren zur herstellung von benzofuranonoximen
DE60133304D1 (de) L-glutamine produzierende mikroorganismen und verfahren zur herstellung von l-glutamine unter verwendung derselben
ATE504603T1 (de) Verfahren zur herstellung von interessanten polypeptiden aus fusionspolypeptiden
WO2002099092A8 (en) Production of recombinant human lysosomal alpha-mannosidase
DE602005016857D1 (de) Verfahren zur Herstellung von Tripeptid-Zwischenprodukten zur Herstellung von LHRH-Antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1546328

Country of ref document: EP

REN Ceased due to non-payment of the annual fee